Seiamak Bahram, MD, PhD, is Professor of Medicine (Immunology) at the Strasbourg University School of Medicine and Teaching Hospitals, Strasbourg, France. He is a senior member of the “Institut universitaire de France” (IUF).
He graduated from the Strasbourg School of Medicine upon which he did his PhD research at the Dana-Farber Cancer Institute – Harvard Medical School (Boston, USA). Upon returning to Europe, he accepted a position as a member of the Basel Institute for Immunology (Roche, Basel, Switzerland). He then moved back to Strasbourg, first as an Associate and then full Professor at the school of Medicine. Additionally, he is the head of the Department of Immunology at Strasbourg University Hospitals.
His research aims at understanding the genetic basis of the immune response in man with emphasis on non-conventional histocompatibility genes. He is internationally known for the identification of several immune response genes, notably the MHC class I chain-related MIC genes. He is the director of INSERM Unit 1109 and the Laboratory of Excellence (LabEx) Transplantex. Seiamak serves as an advisor to GenDx on a broad range of issues with regards to histocompatibility, and especially as to the involvement of MICA and MICB in graft rejection and graft-versus-host disease.